These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4546284)

  • 1. Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.
    Kauffman CA; Phair JP; Linnemann CC; Schiff GM
    Infect Immun; 1974 Jul; 10(1):212-5. PubMed ID: 4546284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the response of lymphocytes to phytohemagglutinin in rubella.
    McMorrow LE; Vesikari T; Wolman SR; Giles JP; Cooper LZ
    J Infect Dis; 1974 Nov; 130(5):464-9. PubMed ID: 4423757
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections.
    Kauffman CA; Linnemann CC; Tan JS; Schiff GM; Phair JP
    Infect Immun; 1974 Oct; 10(4):757-61. PubMed ID: 4372179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation.
    Smith KA; Chess L; Mardiney MR
    Cell Immunol; 1973 Aug; 8(2):321-7. PubMed ID: 4725863
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of specific antigen-sensitized T-lymphocytes in human tonsils.
    Morag A; Morag B; Ogra PL
    J Immunol Methods; 1975; 8(1-2):61-6. PubMed ID: 1080177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon production in lymphocyte cultures after rubella infection in humans.
    Buimovici-Klein E; Weiss KE; Cooper LZ
    J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutinin by a whole blood method.
    Buimovici-Klein E; Vesikari T; Santangelo CF; Cooper LZ
    Arch Virol; 1976; 52(4):323-31. PubMed ID: 1016065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immunity in experimental rubella infections.
    Cappel R
    Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte transformation test using rubella virus antigen].
    Sandow D; Arnold U
    Z Gesamte Hyg; 1974 Sep; 20(9):611-3. PubMed ID: 4462335
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
    Vesikari T; Buimovici-Klein E
    Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus.
    Kanra GY; Vesikari T
    Clin Exp Immunol; 1975 Jan; 19(1):17-32. PubMed ID: 1204239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
    Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
    Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of viral and bacterial pneumonias on cell-mediated immunity in humans.
    Kauffman CA; Linnemann CC; Schiff GM; Phair JP
    Infect Immun; 1976 Jan; 13(1):78-83. PubMed ID: 1082445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A differential effect of IgM and IgG antibodies on the blastogenic response of lymphocytes to rubella virus.
    Lee JC; Sigel MM
    Cell Immunol; 1974 Jul; 13(1):22-31. PubMed ID: 4217654
    [No Abstract]   [Full Text] [Related]  

  • 16. Rubella virus and human lymphocytes in culture.
    Simons MJ; Fitzgerald MG
    Lancet; 1968 Nov; 2(7575):937-40. PubMed ID: 4176262
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired cell-mediated immune response in patients with congenital rubella: correlation with gestational age at time of infection.
    Buimovici-Klein E; Lang PB; Ziring PR; Cooper LZ
    Pediatrics; 1979 Nov; 64(5):620-6. PubMed ID: 386238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of in vitro lymphocyte responses during rubella virus infections.
    Olson GB; Dent PB; Rawls WE; South MA; Montgomery JR; Melnick JL; Good RA
    J Exp Med; 1968 Jul; 128(1):47-68. PubMed ID: 5662017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low level rubella immunity detected by ELISA and specific lymphocyte transformation.
    Buimovici-Klein E; O'Beirne AJ; Millian SJ; Cooper LZ
    Arch Virol; 1980; 66(4):321-7. PubMed ID: 7447708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.